These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 363951)

  • 41. Complement-activating rheumatoid-factor-containing complexes in patients with rheumatoid vasculitis.
    Elson CJ; Scott DG; Blake DR; Bacon PA; Holt PD
    Ann Rheum Dis; 1983 Apr; 42(2):147-50. PubMed ID: 6601932
    [TBL] [Abstract][Full Text] [Related]  

  • 42. OKT3 F(ab')2 fragments--retention of the immunosuppressive properties of whole antibody with marked reduction in T cell activation and lymphokine release.
    Woodle ES; Thistlethwaite JR; Ghobrial IA; Jolliffe LK; Stuart FP; Bluestone JA
    Transplantation; 1991 Aug; 52(2):354-60. PubMed ID: 1908148
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of elevated anti-sarcolemma, anti-idiotype antibody levels with the clinical and pathologic expression of chronic Chagas myocarditis.
    Sadigursky M; von Kreuter BF; Ling PY; Santos-Buch CA
    Circulation; 1989 Nov; 80(5):1269-76. PubMed ID: 2680159
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The specificity of antibodies to the F(ab')2 fragment of human IgG.
    Heimer R; Wolfe LD; Abruzzo JL
    Arthritis Rheum; 1985 May; 28(5):562-8. PubMed ID: 3873943
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Erythropoietin complexed with the F(ab')2 fragment of anti-erythropoietin retains its biologic activity.
    Schooley JC
    Exp Hematol; 1980 Aug; 8(7):830-6. PubMed ID: 16398013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimal conditions for the preparation of Fab and F(ab')2 fragments from monoclonal IgG of different rat IgG subclasses.
    Rousseaux J; Rousseaux-Prévost R; Bazin H
    J Immunol Methods; 1983 Nov; 64(1-2):141-6. PubMed ID: 6644029
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantitative immunoassay for IgA class circulating immune complexes using solid phase Facb fragment of anti-C3.
    Hosoda K; Sakurabayashi I; Kawai T; Suzuki H; Maeda M; Tsuji A
    J Immunol Methods; 1985 Oct; 82(2):243-52. PubMed ID: 3900216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Purification of soluble immune complexes from serum using polymethylmetacrylate beads coated with conglutinin or C1q. Application to the analysis of the components of in vitro formed immune complexes and of immune complexes occurring in vivo during leishmaniasis.
    Casali P; Lambert PH
    Clin Exp Immunol; 1979 Aug; 37(2):295-309. PubMed ID: 498587
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preparation of a bispecific F(ab')2 targeted to the human IL-2 receptor.
    Tso JY; Wang SL; Levin W; Hakimi J
    J Hematother; 1995 Oct; 4(5):389-94. PubMed ID: 8581374
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation.
    Ledbetter JA; June CH; Martin PJ; Spooner CE; Hansen JA; Meier KE
    J Immunol; 1986 Jun; 136(11):3945-52. PubMed ID: 3084650
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prolonged survival of corneal allografts incubated in alloantibody fragments.
    Gebhardt BM; Varnell ED; Kaufman HE
    Transplantation; 1999 Feb; 67(4):594-9. PubMed ID: 10071033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of the F(ab')2 and Fab' fragments prepared from a mouse monoclonal insulin antibody.
    Diaz-Alonso JM; Kohnert KD; Witt S; Ziegler M
    Allerg Immunol (Leipz); 1990; 36(2):95-101. PubMed ID: 2118298
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [IgM Antibody against IgG Antibody Binding to Antigen, So-Called Anti-Antibody, Reacts Mainly with F (ab')₂ Fragment Possessing Antibody Activity].
    Matsuura T; Imamura A; Ota T
    Rinsho Byori; 2017 Jan; 65(1):13-18. PubMed ID: 30695506
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Allergen-sensitive atopic dermatitis is improved by injections of allergen combined with F(ab')2 fragments of specific antibodies.
    Leroy BP; Jacquemin MG; Lachapelle JM; Saint-Remy JM
    Br J Dermatol; 1995 Apr; 132(4):599-603. PubMed ID: 7748752
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nature of circulating immune complexes in infective endocarditis.
    Burton-Kee J; Morgan-Capner P; Mowbray JF
    J Clin Pathol; 1980 Jul; 33(7):653-9. PubMed ID: 7430371
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of (99m)Tc-labeled PR81 and its F(ab')₂ fragments as radioimmunoscintigraphy agents for breast cancer imaging.
    Salouti M; Babaei MH; Rajabi H; Foroutan H; Rasaee MJ; Rajabi AB; Mohammadnejad J; Shafiee M; Mazidi M; Daha FJ
    Ann Nucl Med; 2011 Feb; 25(2):87-92. PubMed ID: 21061190
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of the electric charge of the antigen and the immune complex (IC) lattice on the IC activation of human complement.
    Michelin MA; Crott LS; Assis-Pandochi AI; Coimbra TM; Teixeira JE; Barbosa JE
    Int J Exp Pathol; 2002 Apr; 83(2):105-10. PubMed ID: 12084047
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F(ab')2 specific for the proliferating smooth muscle cells of human atheroma. Imaging with conventional and negative charge-modified antibody fragments.
    Narula J; Petrov A; Bianchi C; Ditlow CC; Lister BC; Dilley J; Pieslak I; Chen FW; Torchilin VP; Khaw BA
    Circulation; 1995 Aug; 92(3):474-84. PubMed ID: 7634463
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development and validation of an antigen-binding capture ELISA for native and putrescine-modified anti-tetanus F(ab')2 fragments for the assessment of the cellular uptake and plasma kinetics of the antibodies.
    Welfringer F; d'Athis P; Scherrmann JM; Hervé F
    J Immunol Methods; 2005 Dec; 307(1-2):82-95. PubMed ID: 16305797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.